Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin

Technology appraisal guidance
Reference number: TA402
Published: 24 August 2016

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 162 KB)

Published:

24 August 2016

Final appraisal determination: 1

Final appraisal determination: 1
Final appraisal determination document (PDF 348 KB)

Published:

20 July 2016
Committee papers (PDF 1.04 MB)

Published:

20 July 2016

Invitation to participate

Final scope (PDF 54 KB)

Published:

17 March 2016
Final matrix (PDF 94 KB)

Published:

17 March 2016

Consultation documents published: TA309 FAD2

Committee papers TA309 FAD2 Evaluation Report (PDF 1.97 MB)

Published:

24 August 2016

Consultation documents published: TA309 ACD3

Committee papers TA309 ACD3 Evaluation Report (PDF 1.98 MB)

Published:

24 August 2016

Consultation documents published: TA309 ACD2

Committee papers TA309 ACD2 Evaluation Report (PDF 3.29 MB)

Published:

24 August 2016

Consultation documents published: TA309 FAD1

Committee papers TA309 FAD1 Evaluation Report (PDF 3.05 MB)

Published:

24 August 2016

Consultation documents published: TA309 ACD1

Committee papers TA309 ACD1 Evaluation Report (PDF 7.08 MB)

Published:

24 August 2016